The beauty of a book does not diminish over time

David Carlson My wife and I had just returned from graduate school in Scotland in 1975 when I was offered a job with troubled teens at a suburban Chicago hospital. I remember being amazed to learn that my salary would be $ 11,000 per year, far more than anything I …

Read More »

Gower author publishes science fiction novel | Life

“The Lermen War: Humanity’s First Contact”, a new book by James Taylor, has been published by Dorrance Publishing Co., Inc. In 2100, humanity begins to explore the vast expanses of the galaxy. At 9:45 p.m., they have their first contact with the Lermens. After years of tension, in 2252, war …

Read More »

New non-coding RNAs regulate blood vessel formation

Researchers at the University of Eastern Finland have discovered previously unknown non-coding RNAs (ncRNAs) involved in the regulation of gene expression of vascular endothelial growth factors (VEGF), the main regulators of angiogenesis. The study, led by the research groups of Associate Professor Minna Kaikkonen-Määttä and Academy Professor Seppo Ylä-Herttuala, provides …

Read More »

One of Australia’s best writers

The one for whom we had the greatest hopes.Your writing, dense with allusion, led us To anticipate that you would be our Joyce,Nabokov, Borges. Looking back I would venture We were perhaps too easily impressedBy your learning, ours being a country Where the word mandarin only meansOrange. Or a necklace …

Read More »

Irish authors shortlisted for several grand prizes

In Saturday’s Irish Times, Lisa McInerney tells me about her new novel, The Rules of Revelation. Louise Nealon talks to Edel Coffey about her first novel, Snowflake; and Rachel Donohue writes about heat waves in literature, a hallmark of her second novel, The Beauty of Impossible Things. Critics include Eoin …

Read More »

Aptorum Group enters into an agreement with Exeltis to develop Aptorum’s new preclinical candidate targeting gynecological conditions in women

NEW YORK & LONDON & PARIS – (BUSINESS WIRE) – Regulatory news: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Aptorum”), a clinical-stage biopharmaceutical company, has entered into an agreement with Exeltis (“Exeltis”) (a division of the global pharmaceutical group Insud Pharma) to develop, manufacture and market …

Read More »